Erasca (ERAS) News Today $2.54 +0.09 (+3.67%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Stake in Erasca, Inc. (NASDAQ:ERAS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Erasca, Inc. (NASDAQ:ERAS - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 364,085 shares of the company'sDecember 19 at 3:15 AM | marketbeat.comErasca (NASDAQ:ERAS) Shares Gap Up - Should You Buy?Erasca (NASDAQ:ERAS) Shares Gap Up - Here's What HappenedDecember 17, 2024 | marketbeat.comPoint72 Asset Management L.P. Reduces Holdings in Erasca, Inc. (NASDAQ:ERAS)Point72 Asset Management L.P. reduced its stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 93.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,599 shares of the company's stock after selling 971,628 shares during the quaDecember 14, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 390,209 Shares of Erasca, Inc. (NASDAQ:ERAS)Charles Schwab Investment Management Inc. increased its stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 29.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,723,630 shares of the company's stock after purchasing an additional 390December 14, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Increases Position in Erasca, Inc. (NASDAQ:ERAS)Frazier Life Sciences Management L.P. grew its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 19.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 19,391,687 shares of the company's stock after purchasing an additional 3,175,471 shares duDecember 10, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Stock Position Decreased by Janus Henderson Group PLCJanus Henderson Group PLC decreased its position in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 49.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,109,548 shares of the company's stock after selling 4,068,544 shares durDecember 9, 2024 | marketbeat.comWalleye Capital LLC Boosts Holdings in Erasca, Inc. (NASDAQ:ERAS)Walleye Capital LLC raised its stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 41.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 949,557 shares of the company's stock after acquiring an addiDecember 4, 2024 | marketbeat.comFred Alger Management LLC Takes Position in Erasca, Inc. (NASDAQ:ERAS)Fred Alger Management LLC bought a new stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 230,854 shares of the company's stock, valued at approximately $630,000. FredDecember 2, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Shares Sold by Sio Capital Management LLCSio Capital Management LLC trimmed its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 22.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,219,186 shares of the company's stock aftNovember 29, 2024 | marketbeat.comErasca initiated with a Buy at JefferiesNovember 19, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Erasca (ERAS) with Buy RecommendationNovember 19, 2024 | msn.comErasca (NASDAQ:ERAS) Shares Gap Up - Time to Buy?Erasca (NASDAQ:ERAS) Shares Gap Up - Still a Buy?November 18, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Receives Average Recommendation of "Moderate Buy" from BrokeragesErasca, Inc. (NASDAQ:ERAS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy ratinNovember 18, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Now Covered by Jefferies Financial GroupJefferies Financial Group assumed coverage on shares of Erasca in a research report on Monday. They issued a "buy" rating and a $6.00 price objective for the company.November 18, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for Erasca FY2024 Earnings?Erasca, Inc. (NASDAQ:ERAS - Free Report) - Research analysts at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of Erasca in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst A. Maldonado now forecasts that theNovember 18, 2024 | marketbeat.comBank of America Securities Sticks to Its Hold Rating for Erasca (ERAS)November 15, 2024 | markets.businessinsider.comErasca, Inc. Reports Strong Progress in Oncology PipelineNovember 15, 2024 | markets.businessinsider.comErasca, Inc.: Erasca Reports Third Quarter 2024 Business Updates and Financial ResultsNovember 13, 2024 | finanznachrichten.deErasca (ERAS) Gets a Buy from Morgan StanleyNovember 13, 2024 | markets.businessinsider.comErasca’s Innovative Naporafenib Shows Promise in NRAS-mutant Melanoma, Garnering Buy Rating from AnalystNovember 13, 2024 | markets.businessinsider.comErasca's (ERAS) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $6.00 target price on shares of Erasca in a research report on Wednesday.November 13, 2024 | marketbeat.comErasca Reports Third Quarter 2024 Business Updates and Financial ResultsNovember 12, 2024 | globenewswire.comErasca to Present at Upcoming Investor ConferencesNovember 5, 2024 | globenewswire.comErasca Insiders Added US$1.95m Of Stock To Their HoldingsOctober 31, 2024 | finance.yahoo.comErasca (NASDAQ:ERAS) Stock Price Up 3.8% - Here's WhyErasca (NASDAQ:ERAS) Trading 3.8% Higher - What's Next?October 29, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Trading Down 3.4% - What's Next?Erasca (NASDAQ:ERAS) Stock Price Down 3.4% - Should You Sell?October 28, 2024 | marketbeat.comErasca (NASDAQ:ERAS) PT Raised to $3.50The Goldman Sachs Group increased their price target on Erasca from $3.00 to $3.50 and gave the stock a "buy" rating in a report on Friday.October 25, 2024 | marketbeat.comErasca announces clinical progress for naporafenibOctober 25, 2024 | markets.businessinsider.comErasca Announces Strong Momentum for Naporafenib and RAS Targeting FranchiseOctober 24, 2024 | markets.businessinsider.comErasca: New Focus After Restructuring, But Need More DifferentiationSeptember 30, 2024 | seekingalpha.comMarshall Wace LLP Makes New Investment in Erasca, Inc. (NASDAQ:ERAS)Marshall Wace LLP bought a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,672,375 shares of the company's stock, valued at approximately $8,September 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Invests $38.27 Million in Erasca, Inc. (NASDAQ:ERAS)Frazier Life Sciences Management L.P. acquired a new position in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 16,216,216 shares of the company's stock, valued at approximately $38September 29, 2024 | marketbeat.comAffinity Asset Advisors LLC Invests $5.90 Million in Erasca, Inc. (NASDAQ:ERAS)Affinity Asset Advisors LLC purchased a new position in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,499,431 shares of the company's stock, valued at approximatelySeptember 25, 2024 | marketbeat.comLogos Global Management LP Acquires New Shares in Erasca, Inc. (NASDAQ:ERAS)Logos Global Management LP acquired a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,900,000 shares of the company's stock, valued at approSeptember 24, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) is favoured by institutional owners who hold 61% of the companySeptember 24, 2024 | finance.yahoo.comSofinnova Investments Inc. Makes New $4.01 Million Investment in Erasca, Inc. (NASDAQ:ERAS)Sofinnova Investments Inc. bought a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,699,528 shares of the company's stock, valued at approximately $4,011,000September 17, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Shares Down 2% Erasca (NASDAQ:ERAS) Shares Down 2%September 13, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Shares Up 5%Erasca (NASDAQ:ERAS) Trading 5% HigherSeptember 5, 2024 | marketbeat.comErasca to Present at Upcoming Investor Conferences in SeptemberAugust 29, 2024 | finance.yahoo.comVanguard Group Inc. Acquires 545,765 Shares of Erasca, Inc. (NASDAQ:ERAS)Vanguard Group Inc. increased its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 14.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,338,108 shares of the company's stock afterAugust 16, 2024 | marketbeat.comMorgan Stanley Keeps Their Buy Rating on Erasca (ERAS)August 15, 2024 | markets.businessinsider.comQ3 2024 EPS Estimates for Erasca, Inc. (NASDAQ:ERAS) Cut by Capital One FinancialErasca, Inc. (NASDAQ:ERAS - Free Report) - Capital One Financial cut their Q3 2024 earnings estimates for shares of Erasca in a research report issued on Monday, August 12th. Capital One Financial analyst N. Quibria now expects that the company will post earnings per share of ($0.21) for the quarAugust 15, 2024 | marketbeat.comErasca stock target raised on SEACRAFT-2 study optimismAugust 15, 2024 | uk.investing.comWe're Hopeful That Erasca (NASDAQ:ERAS) Will Use Its Cash WiselyAugust 15, 2024 | finance.yahoo.comErasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid FinancialsAugust 13, 2024 | markets.businessinsider.comErasca (NASDAQ:ERAS) Releases Quarterly Earnings Results, Misses Estimates By $0.12 EPSErasca (NASDAQ:ERAS - Get Free Report) announced its earnings results on Monday. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.12).August 13, 2024 | marketbeat.comErasca’s Innovative Melanoma Treatments Prompt Buy RatingAugust 13, 2024 | markets.businessinsider.comErasca (NASDAQ:ERAS) Price Target Increased to $6.00 by Analysts at HC WainwrightHC Wainwright increased their price target on shares of Erasca from $5.00 to $6.00 and gave the stock a "buy" rating in a research note on Tuesday.August 13, 2024 | marketbeat.comErasca Reports Second Quarter 2024 Business Updates and Financial ResultsAugust 12, 2024 | globenewswire.comErasca, Inc. (NASDAQ:ERAS) Short Interest Up 9.0% in JulyErasca, Inc. (NASDAQ:ERAS - Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 21,810,000 shares, a growth of 9.0% from the June 30th total of 20,010,000 shares. Based on an average daily volume of 2,300,000 shares, the short-interest ratio is currently 9.5 days. Currently, 13.1% of the company's shares are short sold.July 30, 2024 | marketbeat.com Get Erasca News Delivered to You Automatically Sign up to receive the latest news and ratings for ERAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ERAS Media Mentions By Week ERAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERAS News Sentiment▼1.150.60▲Average Medical News Sentiment ERAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERAS Articles This Week▼22▲ERAS Articles Average Week Get Erasca News Delivered to You Automatically Sign up to receive the latest news and ratings for ERAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Twist Bioscience News ACADIA Pharmaceuticals News MorphoSys News SpringWorks Therapeutics News Zai Lab News Vericel News Gemini Therapeutics News Kymera Therapeutics News Vera Therapeutics News Bausch Health Companies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ERAS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Erasca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Erasca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ERAS Stock Alerts